Pérez Luis Alfonso, González Diana Marcela, Álvarez Karen Margarita de Jesús, Díaz-Martínez Luis Alfonso
Unidad Neonatal, Departamento de Pediatría, Departamento de Pediatría, Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia.
Programa de Especialización en Pediatría, Departamento de Pediatría, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C, Colombia.
Biomedica. 2014 Oct-Dec;34(4):612-23. doi: 10.1590/S0120-41572014000400015.
Continuous positive airway pressure (CPAP) is useful in low birth weight infants with respiratory distress, but it is not known if it is a better alternative to mechanical ventilation after early pulmonary surfactant administration.
To compare the incidence of adverse events in 28 to 32-week newborns with respiratory distress managed with mechanical ventilation or CPAP after early surfactant administration.
In total, 176 newborns were treated with CPAP and 147 with mechanical ventilation, all with Apgar scores >3 at five minutes and without apnea.
The incidence of CPAP failure was 6.5% (95% CI: 11.3-22.8%); 29 patients died: 7 with CPAP (4.0%) and 22 with mechanical ventilation (15.0%, p<0.001). The relative risk of dying with CPAP versus mechanical ventilation was 0.27 (95% CI: 0.12-0.61), but after adjusting for confounding factors, CPAP use did not imply a higher risk of dying (RR=0.60; 95% CI: 0.29-1.24). Mechanical ventilation fatality rate was 5.70 (95% CI: 3.75-8.66) deaths/1,000 days-patient, while with CPAP it was 1.37 (95% CI: 0.65-2.88, p<0.001). Chronic lung disease incidence was lower with CPAP than with mechanical ventilation (RR=0.71; 95% CI: 0.54-0.96), as were intracranial hemorrhage (RR=0.28, 95% CI: 0.09-0.84) and sepsis (RR=0.67; 95%CI: 0.52-0.86), and it was similar for air leaks (RR=2.51; 95% CI: 0.83-7.61) and necrotizing enterocolitis (RR=1.68, 95% CI: 0.59-4.81).
CPAP exposure of premature infants with respiratory distress syndrome is protective against chronic lung disease, intraventricular hemorrhage and sepsis compared to mechanical ventilation. No differences were observed regarding air leak syndrome or death.
持续气道正压通气(CPAP)对患有呼吸窘迫的低体重婴儿有用,但在早期给予肺表面活性物质后,它是否是机械通气的更好替代方法尚不清楚。
比较在早期给予表面活性物质后,采用机械通气或CPAP治疗的28至32周呼吸窘迫新生儿的不良事件发生率。
总共176例新生儿接受CPAP治疗,147例接受机械通气治疗,所有患儿5分钟时阿氏评分均>3且无呼吸暂停。
CPAP失败发生率为6.5%(95%置信区间:11.3 - 22.8%);29例患儿死亡:7例死于CPAP(4.0%),22例死于机械通气(15.0%,p<0.001)。与机械通气相比,使用CPAP死亡的相对风险为0.27(95%置信区间:0.12 - 0.61),但在调整混杂因素后,使用CPAP并不意味着更高的死亡风险(相对风险=0.60;95%置信区间:0.29 - 1.24)。机械通气的病死率为5.70(95%置信区间:3.75 - 8.66)例死亡/1000天 - 患者,而CPAP为1.37(95%置信区间:0.65 - 2.88,p<0.001)。CPAP治疗的慢性肺病发生率低于机械通气(相对风险=0.71;95%置信区间:0.54 - 0.96),颅内出血(相对风险=0.28,95%置信区间:0.09 - 0.84)和败血症(相对风险=0.67;95%置信区间:0.52 - 0.86)的发生率也较低,而气胸(相对风险=2.51;95%置信区间:0.83 - 7.61)和坏死性小肠结肠炎(相对风险=1.68,95%置信区间:0.59 - 4.81)的发生率相似。
与机械通气相比,对患有呼吸窘迫综合征的早产儿使用CPAP可预防慢性肺病、脑室内出血和败血症。在气胸综合征或死亡方面未观察到差异。